Discoveries
Neuroscience
Neuroscience
New technologies are allowing us to explore the brain as never before. We are entering a new era in neuroscience where our knowledge of the brain is beginning to match the urgent need to prevent and treat diseases of the brain.

Neuroscience

CELL REPORTS
03/2025

Astrocyte protein linked to healthy brain connections could inspire new treatments for Alzheimer’s

The connection between two neurons, called a synapse, allows information to flow from one brain cell to the next. Healthy synapses enable us to think, learn, and make memories. However, the exact process for creating and stabilizing new synapses are poorly understood.

Professor Nicola Allen, graduate student Alexandra Bosworth, and colleagues have now shown that nonneuronal brain cells called astrocytes are surprisingly critical for maintaining healthy synapses. Using a mouse model, the researchers found that astrocytes produce a protein called glypican 5 that is necessary for the proper maturation and refinement of synapses. Without glypican 5, synapses lose structural maturity and cause the pre- and post-synaptic portions of neighboring neurons to shrink. This information could now influence the development of new therapeutics for brain disorders that involve synaptic dysfunction, including Alzheimer’s disease and frontotemporal dementia.

Nature Structural & Molecular Biology
05/2025

Action! Proteins critical to healthy brain development captured on film

Our cells rely on microscopic highways and specialized protein vehicles to move everything inside them—from positioning organelles to disposing of cellular garbage. These vehicles, called motor proteins, are indispensable to cellular function and survival, and their dysfunction can lead to severe neurodevelopmental and neurodegenerative disorders. For example, dysfunction of the motor protein dynein or its partner protein Lis1 can lead to a rare fatal birth defect called lissencephaly, or “smooth brain.” Therapeutics that target and restore dynein or Lis1 function could change those dismal outcomes, and developing those therapeutics depends on thoroughly understanding how dynein and Lis1 interact.

Assistant Professor Aga Kendrick, Salk colleagues, and UC San Diego collaborators captured high-resolution movies of Lis1 activating dynein. The movies allowed the team to catalogue 16 shapes that the two proteins take as they interact, some of which have never been seen before. These insights will be foundational for designing future therapeutics that can target these structures and restore dynein and Lis1 function.

Read News Release

Sign up for our monthly newsletter.

Latest discoveries, events & more.